Company · founded 2001
ProThera Biologics (United States)
East Providence, United States · protherabiologics.com
- Citations, last 5 years
- 54
- Works, last 5 years
- 9
- h-index
- 38
- Scientists listed
- 1
- Grants since 2016
- 9
Grants received
2023–2025 · research · R43
Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis
Yow-Pin Lim · ProThera Biologics (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis
Yow-Pin Lim · ProThera Biologics (United States) · funded by National Institutes of Health
2019–2021 · research · R44
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis
Yow-Pin Lim · ProThera Biologics (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis
Yow-Pin Lim · ProThera Biologics (United States) · funded by National Institutes of Health
2018–2019 · research · R44
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis
Yow-Pin Lim · ProThera Biologics (United States) · funded by National Institutes of Health
2018–2027 · research · R44
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis
Yow-Pin Lim · ProThera Biologics (United States) · funded by National Institutes of Health
2018–2027 · research · R44
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis
Yow-Pin Lim · ProThera Biologics (United States) · funded by National Institutes of Health
2014–2021 · research · R44
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury
Yow-Pin Lim · ProThera Biologics (United States) · funded by National Institutes of Health
2014–2026 · research · R44
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury
Yow-Pin Lim · ProThera Biologics (United States) · funded by National Institutes of Health